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Case Report
A 41-year-old Thai female with past medical history of gastroesophageal reflux disease and duodenal ulcer who immigrated
to the United States six years ago presented with a complaint
of intermittent right upper quadrant (RUQ) pain for the last
several years. Over the last year, she reported that the pain had
significantly increased in intensity. She described the pain as
crampy, beginning in the RUQ and radiating around to her
back. There was no associated nausea, vomiting or weight loss.
The patient had initially presented to an outside hospital a few
months prior, was diagnosed with costochondritis, and was
subsequently discharged. Her family promptly drove her to the
emergency room of the outside hospital with severe abdominal
pain and fevers. A computed tomography (CT) scan done in
the emergency room showed a 4.6 cm x 2.8 cm x 4.9 cm multiloculated mass adjacent to the head of the pancreas along with
several enlarged lymph nodes in close proximity to the mass. The
patient was referred to an oncologist at a specialty cancer center
where an endoscopic ultrasound (EUS) was performed. The EUS
revealed a 5.1 cm x 2.2 cm hypoechoic, heterogeneous, septated
lesion. Fine needle aspiration (FNA) was performed on the mass
and cytology was sent to determine the etiology of the peripancreatic mass. The EUS-FNA cytology demonstrated necrotizing
granulomatous inflammation, but specials stains for tuberculosis
and fungal etiologies were negative. Peripancreatic fluid, porta
hepatis fluid and sputum cultures at this time were all negative.

Figure 1. Abdominal CT showing a multiloculated cystic mass in
the porta hepatis, portacaval, and peripancreatic regions.

On admission, the patient’s vital signs were stable. She was alert,
awake, and oriented. She had a normal temperature on admission
but became febrile to 102 F in the emergency room. Her heart
and lung exam were within normal limits. On abdominal
exam, she was found to have significant RUQ and epigastric
tenderness, with no distention, rebound, or guarding. She had
normally active bowel sounds with no palpable organomegaly.
At presentation, her white blood cell count was slightly elevated
at 11.1 x 103 /μL but the rest of her complete blood count panel
and basic metabolic panel were within normal limits. Her
amylase was 85 IU/L, and her lipase was 20 IU/L. Her hepatic
function panel was within normal limits except for a slightly
elevated alkaline phosphatase level at 108 IU/L.
After being transferred to Thomas Jefferson University Hospital, a
chest CT and repeat abdominal CT and EUS were performed. The
CT of the abdomen showed a multiloculated cystic mass in the
porta hepatis, portacaval, and peripancreatic region measuring
approximately 4.3 cm x 3.1 cm (Figure 1). Additionally, severe
narrowing of the distal main portal vein and narrowing of the
left portal vein from the adjacent mass were described. The porta
hepatis component of the mass had slightly increased in size and
demonstrated increased cystic changes and increased compression
of the main portal vein and left portal vein in comparison to a
CT done a month ago. The pancreas itself was not involved and
appeared unremarkable, but had been displaced by the mass. No
pancreatic ductal dilatation was observed.

Figure 2. CT chest demonstrating bilateral upper lobe tree-in-bud
opacities suggestive of infectious or inflammatory processes and
endobronchial spread of infection.
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Figure 3. EUS illustrating a hypoechoic, lobular, homogeneous
mass lesion present adjacent to the pancreatic head and
compressing the portal vein.

Figure 5. A cell block sample of the aspirate showing a classic
granuloma with a multi-nucleated giant cell surrounded by
epithelioid histiocytes in the background of lymphocytes and
necrotic debris.
and tail. Several 1 cm, oval, heterogeneous peri-pancreatic
lymph nodes with poorly defined margins were also found.
Examination of the fluid aspirated from the pancreatic lesions
showed a collection of epithelioid histiocytes in a background
of inflammatory cells and debris (Figure 4). Additionally, a cell
block sample of the aspirate showed a classic granuloma with a
multi-nucleated giant cell surrounded by epithelioid histiocytes
in a background of lymphocytes and necrotic debris (Figure 5).
Staining of the fluid culture from the porta hepatis and peripancreatic masses were negative with specialty stains for acid-fast
bacilli, but cultures eventually grew out mycobacterium
tuberculosis (MTB) complex after 5 weeks. The state health
department was notified. Follow up was arranged upon
discharge for continuation of MTB treatment.

Figure 4. Cytology from aspiration of porta hepatis and peripancreatic masses showing a collection of epithelial histiocytes in the
background of inflammatory cells and debris
The chest CT demonstrated bilateral upper-lobe “tree-in-bud”
opacities suggestive of infectious or inflammatory processes
including endobronchial spread of infection, such as seen with
tuberculosis (TB) (Figure 2). The differential diagnosis also
included other atypical mycobacterial organisms, viruses and
fungal etiologies.
The repeat EUS described a 4.3 cm x 2.8 cm hypoechoic,
lobular, homogeneous lesion present adjacent to the pancreatic
head (Figure 3). The mass had a cystic component to it and
compressed but did not invade the portal vein. The entire
pancreas appeared normal with full visualization of the body
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Discussion
MTB is an acid-fast bacillus that causes an infection known as
tuberculosis. TB is characterized by chronic granulomas and
had been a common disease of undeveloped countries decades
ago, but has been well controlled with advancing antibiotic
therapies more recently. Over the last few years however, there
has been a rise in the incidence even in developed countries
such as the United States due to increasing numbers of patients
with immunocompromised states and due to increasing
numbers of immigrants from areas with endemic TB.1,2,4,5,7 TB
is a disease that can present almost anywhere in the body, but
is most routinely discovered in the lungs. For example, TB of
the digestive tract can occur anywhere from the esophagus to
the anus. Additionally, tuberculosis can present as an abdominal
infection, localizing in the liver, spleen, or ileocecal region
resulting in non-specific findings such as fever, pain, malaise,
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weakness, weight loss, anorexia, and jaundice.1,2,-5,7 Pancreatic
TB, is exceptionally rare with only a handful of cases having
been published.1,3,5 The reasoning behind this is unclear, but
it is hypothesized that digestive pancreatic enzymes interfere
with the seeding of mycobacterium into the pancreatic tissue.4,7
Pancreatic TB currently is being diagnosed more frequently,
partly because of the increase in immunodeficient patients and
partly due to improved pancreatic imaging.
Pancreatic TB is often indistinguishable from pancreatic tumors
on CT imaging because both present as non-specific lesions in
the pancreas; FNA with cytology is needed to make a definitive
diagnosis.1,3,4 Positron emission tomography (PET) scanning
is typically used to differentiate cancerous lesions from other
concerning processes, but is not useful with TB related lesions,
which can cause an increased uptake on PET scans, notably
in the lungs.6 Low-attenuation peripancreatic and periportal
adenopathy with peripheral rim enhancement may support
a diagnosis of pancreatic TB on CT.2 In an article by Xia, in
which characteristics of pancreatic TB were elicited via 16
patients and 58 prior literature reports, some associations and
possible ways to distinguish pancreatic TB from pancreatic
tumor were identified. Xia found that young people and females
were more likely to have pancreatic TB, whereas pancreatic
cancer was more commonly found in males and the elderly.
Moreover, it was found that not all people had a past history of
TB, but most who develop pancreatic TB come from a region
known to be endemic for TB. The most common symptoms
that patients complained of were epigastric pain, fever, and
weight loss, though these were not specific to pancreatic TB.1-5,7
Lastly, it was found that FNA with tissue cytology was the most
definitive non-surgical way to diagnose pancreatic TB and rule
out carcinoma.1,4-7
The spread of TB to the pancreas is poorly understood, but may
occur as one of a number of different forms of infection. It may
come from generalized, or military TB, in which case MTB is
the most common causative agent. Spread to the pancreas can
occur as a result of seeding from celiac, retroperitoneal, or
peripancreatic lymph nodes. In this case, Mycobacterium bovis
is likely the infectious agent.1,6,7 Also, spread to the pancreas may

result from hematogenous dissemination of bacteria from the
lungs.2,6,7 Lastly, a primary localized pancreatic TB may be seen.
This is a very rare form of TB, which points to the intestinal
tract as the root of infection.1,6

Conclusion
Pancreatic TB is a rare but serious condition. The variability in
imaging of pancreatic TB poses potential diagnostic problems.
Pancreatic TB is curable with standard antibiotics if it is
diagnosed early enough, but delay of diagnosis or misdiagnosis
can potentially be fatal.2,3 In immunocompromised patients
or young patients from areas endemic with TB in whom TB
is clinically suspected, EUS-FNA should be performed in
order to determine the etiology of the pancreatic lesion. 4,5
The obtained sample should be sent for an acid-fast bacilli
stain, as a preliminary test for mycobacterium species, even
though the yield is low. Cultures should also be sent, though
they can take up to six to eight weeks grow for definitive rule
out.5 Patients should be started on antibiotics as soon as TB is
clinically suspected. Often, they do very well with few lasting
complications once treatment begins.
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